Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,394 | 14,415 | 2,124 | 3,806 | 7,229 |
| Other current assets | 283 | 305 | 346 | 0 | 0 |
| TOTAL | $14,039 | $15,265 | $3,209 | $4,514 | $8,102 |
| Non-Current Assets | |||||
| PPE Net | 6 | 6 | 7 | 10 | 11 |
| Other Non-Current Assets | 1 | 1 | 189 | 216 | 243 |
| TOTAL | $7 | $7 | $196 | $225 | $254 |
| Total Assets | $14,046 | $15,272 | $3,405 | $4,739 | $8,356 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 207 | 172 | 448 | 265 | 919 |
| Accrued Expenses | 272 | 308 | 775 | 424 | 435 |
| TOTAL | $824 | $984 | $1,848 | $690 | $1,446 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 64 | 95 | 126 |
| TOTAL | $N/A | $N/A | $64 | $95 | $126 |
| Total Liabilities | $824 | $989 | $1,912 | $785 | $1,572 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 298 | 272 | 280 | 28 | 16 |
| Common Shares | 2 | 2 | 0 | 3 | 3 |
| Retained earnings | -292,055 | -290,949 | -289,542 | -286,993 | -284,077 |
| TOTAL | $13,222 | $14,278 | $1,493 | $3,954 | $6,784 |
| Total Liabilities And Equity | $14,046 | $15,267 | $3,405 | $4,739 | $8,356 |